A detailed history of China Universal Asset Management Co., Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 21,000 shares of NVO stock, worth $2.14 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
21,000
Previous 20,000 5.0%
Holding current value
$2.14 Million
Previous $2.85 Million 12.4%
% of portfolio
0.28%
Previous 0.41%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$119.07 - $145.42 $119,070 - $145,420
1,000 Added 5.0%
21,000 $2.5 Million
Q2 2024

Jul 19, 2024

SELL
$122.71 - $146.91 $2.56 Million - $3.07 Million
-20,896 Reduced 51.1%
20,000 $2.85 Million
Q3 2023

May 21, 2024

BUY
$90.94 - $199.54 $1.86 Million - $4.08 Million
20,448 Added 100.0%
40,896 $3.72 Million
Q3 2023

Oct 30, 2023

BUY
$90.94 - $199.54 $1.86 Million - $4.08 Million
20,448 Added 100.0%
40,896 $3.72 Million
Q1 2023

May 21, 2024

BUY
$132.34 - $159.14 $1.19 Million - $1.43 Million
9,008 Added 78.74%
20,448 $3.25 Million
Q1 2023

Apr 27, 2023

BUY
$132.34 - $159.14 $1.19 Million - $1.43 Million
9,008 Added 78.74%
20,448 $3.27 Million
Q4 2022

May 21, 2024

SELL
$102.55 - $135.33 $3.02 Million - $3.99 Million
-29,456 Reduced 72.03%
11,440 $1.55 Million
Q4 2022

Jan 31, 2023

SELL
$102.55 - $135.33 $2.77 Million - $3.65 Million
-26,979 Reduced 70.22%
11,440 $1.55 Million
Q3 2022

Oct 21, 2022

BUY
$95.28 - $116.93 $309,469 - $379,788
3,248 Added 9.23%
38,419 $3.83 Million
Q2 2022

Aug 12, 2022

BUY
$103.24 - $121.81 $3.63 Million - $4.28 Million
35,122 Added 71677.55%
35,171 $3.92 Million
Q4 2021

Feb 11, 2022

BUY
$95.88 - $117.08 $4,698 - $5,736
49 New
49 $5,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.